Loading
Latest filing published 29 Sept 2025 for Medexus Pharmaceuticals Inc. (formerly Pediapharm Inc.), €34k.
Harmony Phillips Garges discloses dealings in Medexus Pharmaceuticals Inc. (formerly Pediapharm Inc.) to SEDI. In total, 4 filings cover trades dated from 6 February 2023 to 25 September 2025.
Not one of the filings records a straightforward purchase or sale on the market. Compensation-driven entries like these are tracked, but they say little about how insiders judge the share price.
The newest entry dates from 29 September 2025: an option exercise of €34k, in Medexus Pharmaceuticals Inc. (formerly Pediapharm Inc.). Filings reach the SEDI feed a median of 4 days after the trade. Until a filing is published, the market cannot know about the trade. This summary is built from SEDI disclosures alone and does not predict where the share price will go.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
4 of 4 declarations